D. Senthil Raja et al. / Inorganica Chimica Acta 385 (2012) 81–93
93
100
References
[
1] V. Milacic, D. Chen, L. Ronconi, K.R. Landis-Piwowar, D. Fregona, Q.P. Dou,
Cancer Res. 66 (2006) 10478.
2] I. Kostova, Anticancer Agents Med. Chem. 6 (2006) 19.
3] Z.A. Siddiqi, M. Khalid, S. Kumar, M. Shahid, S. Noor, Eur. J. Med. Chem. 45
80
60
40
20
0
[
[
(
2010) 264.
4] S. Delaney, M. Pascaly, P.K. Bhattacharya, K. Han, J.K. Barton, Inorg. Chem. 41
2002) 1966.
[
(
Cisplatin (IC50= 9.42
μ
M)
[5] J. Tan, B. Wang, L. Zhu, Bioorg. Med. Chem. 17 (2009) 614.
[6] B.P. Esposito, R. Najjar, Coord. Chem. Rev. 232 (2002) 137.
[7] D.R. Green, J.C. Reed, Science 281 (1998) 1309.
3
2
(IC50= 23.67
(IC50= 32.31
μ
M)
M)
μ
[
8] Y. Ma, L. Cao, T. Kavabata, T. Yoshino, B.B. Yang, S. Okada, Free Radical Biol.
Med. 25 (1998) 568.
9] F. Liang, C. Wu, H. Lin, T. Li, D. Gao, Z. Li, J. Wei, C. Zheng, M. Sun, Bioorg. Med.
Chem. Lett. 13 (2003) 2469.
[
0
20
40
60
80
100
[
[
10] J. Easmon, G. Purstinger, G. Heinisch, T. Roth, H.H. Fiebig, W. Holzer, W. Jager,
M. Jenny, J. Hofmann, J. Med. Chem. 44 (2001) 2164.
11] E.L. Hegg, J.N. Burstyn, Coord. Chem. Rev. 173 (1998) 133.
Conc. of the compounds (
μ
M)
Fig. 12. Cytotoxic activity of compounds (cisplatin, 2 and 3) against HeLa at various
concentrations.
[12] S. Dhar, D. Senapati, P.K. Das, P. Chattopadhyay, M. Nethaji, A.R. Chakravarty, J.
Am. Chem. Soc. 125 (2003) 12118.
[
13] S. Dhar, P.A. Reddy, M. Nethaji, S. Mahadevan, M.K. Saha, A.R. Chakravarty,
Inorg. Chem. 41 (2002) 3469.
[
14] P. Haskova, P. Kovarikova, L. Koubkova, A. Vavrova, E. Mackova, T. Simunek,
Free Radical Biol. Med. 50 (2011) 537.
pounds bound with BSA mainly in tryptophan residues. In addition,
the compounds also exhibited good antioxidant activities and the
activity of 3 is better than that of 2 and 1. The results of cytotoxic-
ity study showed a linear relationship between the concentration
of the Cu(II) complexes and the percentage inhibition of HeLa tu-
mor cell growth without apparent damage to the normal cells.
From the biological activity experiments, we observed that the cat-
ionic Cu(II) nitrate complex (3) which has two methanol molecules
as co-ligands exhibited more potential than the neutral Cu(II) com-
plex containing one water molecule and a chloride ion as co-li-
gands. So, overall, a structural dependent biological activity was
observed which has been explained based on their structures.
The findings are significant for us to explore further the DNA and
protein interaction, antioxidative and cytotoxic activities of the
transition metal complexes containing different 2-oxo-1,2-dihy-
droquinoline-3-carbaldehyde Schiff-bases.
[15] C.M. Moldovan, O. Oniga, A. Parvu, B. Tiperciuc, P. Verite, A. Pirnau, O. Crisan,
M. Bojita, R. Pop, Eur. J. Med. Chem. 46 (2011) 526.
[
16] S. Banerjee, S. Mondal, S. Sen, S. Das, D.L. Hughes, C. Rizzoli, C. Desplanches, C.
Mandal, S. Mitra, Dalton Trans. (2009) 6849.
[17] S. Banerjee, S. Mondal, W. Chakraborty, S. Sen, R. Gachhui, R.J. Butcher, A.M.Z.
Slawin, C. Mandal, S. Mitra, Polyhedron 28 (2009) 2785.
[
18] P. Krishnamoorthy, P. Sathyadevi, A.H. Cowley, R.R. Butorac, N. Dharmaraj, Eur.
J. Med. Chem. 46 (2011) 3376.
[19] Z.-C. Liu, B.-D. Wang, Z.-Y. Yang, Y. Li, D.D. Qin, T.-R. Li, Eur. J. Med. Chem. 44
2009) 4477.
20] Z.-C. Liu, B.-D. Wang, B. Li, Q. Wang, Z.-Y. Yang, T.-R. Li, Y. Li, Eur. J. Med. Chem.
5 (2010) 5353.
(
[
4
[21] D.S. Raja, G. Paramaguru, N.S.P. Bhuvanesh, J.H. Reibenspies, R. Renganathan,
K. Natarajan, Dalton Trans. 40 (2011) 4548.
[
[
[24] G.M. Sheldrick, Acta Crystallogr., Sect. A 64 (2008) 112.
[25] A.L. Spek, Acta Crystallogr., Sect. D 65 (2009) 148.
[
[
[
22] M.K. Singh, A. Chandra, B. Singh, R.M. Singh, Tetrahedron Lett. 48 (2007) 5987.
23] APEX2 and SAINT, Bruker AXS Inc., Madison, Wisconsin, USA.
26] M.S. Blois, Nature 29 (1958) 1199.
27] T. Nash, Biochem. J. 55 (1953) 416.
28] L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, S.R.
Tannenbaum, Anal. Biochem. 126 (1982) 131.
29] C. Beauchamp, I. Fridovich, Anal. Biochem. 44 (1971) 276.
30] J.K. Barton, A.T. Danishefsky, J.M. Goldberg, J. Am. Chem. Soc. 106 (1984) 2172.
31] S.M. Hecht, J. Nat. Prod. 63 (2000) 158.
Acknowledgment
[
[
[
Financial assistance received from the Council of Scientific and
Industrial Research, New Delhi, India (Grant No. 01(2216)/08/EMR-
II & 21(0745)/09/EMR-II), is gratefully acknowledged.
[32] M. Eriksson, M. Leijon, C. Hiort, B. Norden, A. Graeslund, Biochemistry 33
1994) 5031.
[
[
(
33] A. Wolf, G.H. Shimer, T. Meehan, Biochemistry 26 (1987) 6392.
34] A. Nohara, T. Umetani, Y. Sanno, Tetrahydron Lett. 22 (1973) 1995.
Appendix A. Supplementary data
[35] F.J. Meyer-Almes, D. Porschke, Biochemistry 32 (1993) 4246.
[
[
36] G.M. Howe, K.C. Wu, W.R. Bauer, Biochemistry 19 (1976) 339.
37] D.S. Raja, N.S.P. Bhuvanesh, K. Natarajan, Eur. J. Med. Chem. 46 (2011)
Packing diagram of the unit cell showing hydrogen bonding of 2
and 3 has been given in Figs. S1 and S2, respectively. The hydrogen
bonding parameters for 2 and 3 have been given in Tables S1 and
S2, respectively. CCDC 825145 and 825268 contain the supplemen-
tary crystallographic data for complexes 2 and 3, respectively.
4
584.
39] B.P. Kamat, J. Seetharamappa, J. Pharm. Biomed. Anal. 35 (2008) 655.
40] X.Z. Feng, Z. Yang, L.J. Wang, C. Bai, Talanta 47 (1998) 1223.
[41] G.Z. Chen, X.Z. Huang, Z.Z. Zheng, J.G. Xu, Z.B. Wang, Methods of Fluorescence
Analysis, second ed., Science Press, Beijing, 1990
42] J.N. Miller, Proc. Anal. Div. Chem. Soc. 16 (1979) 203.
43] J.H. Tang, F. Luan, X.G. Chen, Bioorg. Med. Chem. 149 (2006) 3210.
[44] D.S. Raja, N.S.P. Bhuvanesh, K. Natarajan, Eur. J. Med. Chem. 47 (2012) 73.
45] D.S. Raja, N.S.P. Bhuvanesh, K. Natarajan, Inorg. Chem. 50 (2011) 12852.
[
[
[
[
[